Phillip L Campbell

Phillip L Campbell

University of Michigan - Ann Arbor / United States
Others
AD Scientific Index ID: 1292228
person_outline Phillip L Campbell's MOST POPULAR ARTICLES
1-) Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trialF Morschhauser, H Tilly, A Chaidos, P McKay, T Phillips, S Assouline, ...The Lancet Oncology 21 (11), 1433-1442, 20204932020
2-) The carbonic anhydrase domain of receptor tyrosine phosphatase β is a functional ligand for the axonal cell recognition molecule contactinE Peles, M Nativ, PL Campbell, T Sakurai, R Martinez, S Levt, DO Clary, ...Cell 82 (2), 251-260, 19954741995
3-) IL-1β and TNF-α in prostatic secretions are indicators in the evaluation of men with chronic prostatitisRB Nadler, AE Koch, EA Calhoun, PL Campbell, DL Pruden, CL Bennett, ...The Journal of urology 164 (1), 214-218, 20004172000
4-) ASCEND: phase III, randomized trial of acalabrutinib versus idelalisib plus rituximab or bendamustine plus rituximab in relapsed or refractory chronic lymphocytic leukemiaP Ghia, A Pluta, M Wach, D Lysak, T Kozak, M Simkovic, P Kaplan, ...Journal of Clinical Oncology 38 (25), 2849-2861, 20203972020
5-) Evaluation of the cytokines interleukin 8 and epithelial neutrophil activating peptide 78 as indicators of inflammation in prostatic secretionsWW Hochreiter, RB Nadler, AE Koch, PL Campbell, M Ludwig, W Weidner, ...Urology 56 (6), 1025-1029, 20002312000